CH642058A5 - Polypeptide sowie diese polypeptide enthaltende arzneimittel. - Google Patents

Polypeptide sowie diese polypeptide enthaltende arzneimittel. Download PDF

Info

Publication number
CH642058A5
CH642058A5 CH1256678A CH1256678A CH642058A5 CH 642058 A5 CH642058 A5 CH 642058A5 CH 1256678 A CH1256678 A CH 1256678A CH 1256678 A CH1256678 A CH 1256678A CH 642058 A5 CH642058 A5 CH 642058A5
Authority
CH
Switzerland
Prior art keywords
gly
cells
gln
thymus
vol
Prior art date
Application number
CH1256678A
Other languages
German (de)
English (en)
Inventor
Gideon Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/960,550 external-priority patent/US4232008A/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of CH642058A5 publication Critical patent/CH642058A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062—Serum thymic factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH1256678A 1977-12-08 1978-12-08 Polypeptide sowie diese polypeptide enthaltende arzneimittel. CH642058A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85849677A 1977-12-08 1977-12-08
US94053178A 1978-09-08 1978-09-08
US05/960,550 US4232008A (en) 1978-11-17 1978-11-17 Tetrapeptides and methods

Publications (1)

Publication Number Publication Date
CH642058A5 true CH642058A5 (de) 1984-03-30

Family

ID=27420392

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1256678A CH642058A5 (de) 1977-12-08 1978-12-08 Polypeptide sowie diese polypeptide enthaltende arzneimittel.

Country Status (19)

Country Link
JP (1) JPS5498719A (it)
CA (1) CA1120031A (it)
CH (1) CH642058A5 (it)
DE (1) DE2853002A1 (it)
DK (1) DK149595C (it)
ES (1) ES475857A1 (it)
FI (1) FI67368C (it)
FR (1) FR2411174A1 (it)
GB (1) GB2014581B (it)
GR (1) GR65013B (it)
IE (1) IE47611B1 (it)
IL (1) IL56150A (it)
IT (1) IT1110889B (it)
NL (1) NL7812004A (it)
NO (1) NO149631C (it)
NZ (1) NZ189101A (it)
PT (1) PT68883A (it)
SE (1) SE444687B (it)
YU (1) YU41322B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
CA1156220A (en) * 1979-04-26 1983-11-01 George Heavner Method and composition for preparation of h-sar-lys-sar-gln-nh.sub.2
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
JPS5711950A (en) 1980-06-25 1982-01-21 Kureha Chem Ind Co Ltd Peptide and its synthesis
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
RU2210382C1 (ru) * 2002-07-09 2003-08-20 Терентьев Александр Александрович Пептид, обладающий иммунорегуляторным свойством, и его композиция

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2544348C3 (de) * 1975-10-03 1979-12-13 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L-Leucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
FR2423481A2 (fr) * 1978-04-21 1979-11-16 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
CA1126261A (en) * 1977-05-25 1982-06-22 Jean-Francois Bach Polypeptides and processes for the synthesis thereof

Also Published As

Publication number Publication date
YU41322B (en) 1987-02-28
IL56150A0 (en) 1979-03-12
PT68883A (en) 1979-01-01
GR65013B (en) 1980-06-12
NO149631C (no) 1984-05-23
GB2014581A (en) 1979-08-30
SE444687B (sv) 1986-04-28
ES475857A1 (es) 1980-01-16
IT1110889B (it) 1986-01-06
DK554078A (da) 1979-06-09
FR2411174A1 (fr) 1979-07-06
NO784128L (no) 1979-06-11
CA1120031A (en) 1982-03-16
YU288078A (en) 1983-02-28
DK149595C (da) 1987-03-23
DK149595B (da) 1986-08-04
FR2411174B1 (it) 1984-05-25
JPS6327360B2 (it) 1988-06-02
NZ189101A (en) 1984-07-06
SE7812614L (sv) 1979-06-09
IT7852239A0 (it) 1978-12-07
NL7812004A (nl) 1979-06-12
JPS5498719A (en) 1979-08-03
NO149631B (no) 1984-02-13
IL56150A (en) 1982-02-28
FI67368B (fi) 1984-11-30
FI67368C (fi) 1985-03-11
IE782423L (en) 1979-06-08
GB2014581B (en) 1982-05-19
FI783769A (fi) 1979-06-09
DE2853002A1 (de) 1979-06-13
IE47611B1 (en) 1984-05-02

Similar Documents

Publication Publication Date Title
DE68923401T2 (de) Peptide mit T-Zellen-Helfer-Wirksamkeit.
DE3100974C2 (it)
DE2450355A1 (de) Aus n-acyl-muraminsaeurederivaten gebildete adjuvanzien und diese enthaltende impfstoffe
EP0025897B1 (de) Neue Peptide und Verfahren zu ihrer Herstellung
DE2847608A1 (de) Glykopeptide und verfahren zu ihrer herstellung
DE2256445A1 (de) Neue heptapeptide mit gastrinwirkung
EP0164654A2 (de) Verfahren zur Herstellung von Pentapeptiden mit Wirkung auf das Immunsystem und Zwischenprodukte dieses Verfahrens
DE2822951A1 (de) Neue polypeptide mit thymusaktivitaet oder antagonistischer aktivitaet und verfahren zu ihrer herstellung
DE2544348C3 (de) L-Leucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
CH642058A5 (de) Polypeptide sowie diese polypeptide enthaltende arzneimittel.
EP0179332A2 (de) Neue ZNS-aktive Peptide mit Wirkung auf das cholinerge System
DE2315271A1 (de) Norleucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel
DE3881467T2 (de) Vasokonstriktor-Peptid.
EP0135722B1 (de) Neue Peptide mit immunstimulierender Wirkung, Verfahren zu deren Herstellung und deren Verwendung
EP0033384B1 (de) Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
CH639941A5 (en) Polypeptides, process for their preparation and their use
DE2804567C2 (de) Pentapeptide, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0080194B1 (de) Neue Peptide und Verfahren zu ihrer Herstellung
EP0003028B1 (de) Beta h-Endorphin-Analoge, diese enthaltende Präparate und deren Herstellung
DE60036638T2 (de) Verwendung von colostrinin, dessen peptidbestandteile und deren analoga zur förderung der neuronalen zelldifferenzierung
AT384812B (de) Verfahren zur herstellung neuer polypeptide
EP0056594B1 (de) Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
EP0491361A2 (de) Kurze Peptide mit Insulinwirkung
DD296084A5 (de) Verfahren zur herstellung von humanen spleninderivaten
DE2114300C3 (de) Octadekapeptide und Arzneipräparate

Legal Events

Date Code Title Description
PL Patent ceased